VivoSeq
Other

Clonidine

0

Pipeline Programs↗

2

Active Trials↗

2

Companies Involved↗

Clonidine is an early-stage landscape with 0 programs across 2 companies. The most active players are Valerio Therapeutics, Boehringer Ingelheim.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

55/100

Attrition Rate

33/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

V

Valerio Therapeutics

0 programs

PreclinicalBoehringer Ingelheim logo

Boehringer Ingelheim

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

15

clinical trials

Completed6 · 40%
Terminated3 · 20%
Recruiting2 · 13%
Withdrawn2 · 13%
Unknown status2 · 13%

Clinical Trials

Trial Activity

15 trials

Repurposing Low-Dose Clonidine for PTSD in Veterans
Recruiting·WWake Forest University Health Sciences·Phase 3·NCT04877093·32 enrolled
Efficacy of Clonidine in Reducing Craving in Inpatients With Cocaine and Crack Use Disorder
Recruiting·UUniversity of Sao Paulo General Hospital·Phase 4·NCT07313371·36 enrolled
Phase 1 PK, Bioavailability, Safety Study of Clonidine MBT w Catapres in Healthy Volunteers
Completed·VValerio Therapeutics·Phase 1·NCT02548806·36 enrolled
Bioequivalence of Two Transdermal Clonidine Administrations in Healthy Volunteers
Completed·Boehringer Ingelheim logoBoehringer Ingelheim·Phase 1·NCT02096744·56 enrolled
Preschool Supplement to Clonidine in ADHD (Kiddie-CAT)
Completed·UUniversity of Cincinnati·Phase 2·NCT00414921·30 enrolled
Pharmacokinetics and Clinical Effects of Escalating Doses of Clonidine in ICU Patients
Completed·—·Phase 3·NCT02466373·32 enrolled
The Effects of Clonidine on the Diuretic Response in Cirrhotic Patients
Completed·CCHU de Charleroi·N/A·NCT00356226·64 enrolled
Effect of Clonidine on Responses to Imagery Scripts
Completed·National Institute on Drug Abuse (NIDA)·Phase 1·NCT00318760·92 enrolled
Use of Transdermal Clonidine in Trauma Patients
Terminated·MMemorial Health University Medical Center·Phase 4·NCT01139996·22 enrolled
Feasibility of Administering Clonidine as a Pharmacological Challenge in Imaging Studies
Terminated·WWeill Medical College of Cornell University·Phase 1·NCT04030572·3 enrolled
An Extended-Release Form of Clonidine as an Anti-Manic Agent: An Add-on, Open-Label Study
Terminated·MMclean Hospital·Phase 4·NCT03065933·5 enrolled
Clonidine to Prevent Implantable Cardiovertor Defibrillator Firing
Withdrawn·—·N/A·NCT00585871
Clonidine for Neurocognitive Sequelae
Withdrawn·Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)·Phase 1/2·NCT00166686
Clonidine as Pain Relief During ROP Eye Examinations
Unknown status·—·Phase 4·NCT04902859·50 enrolled
Clonidine for Tourniquet-related Pain in Children
Unknown status·OOdense University Hospital·Phase 4·NCT04564430·20 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)